Cannabis Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More – Compass Pathways (NASDAQ:CMPS), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta’s Influence – ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana’s Research And More – ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology Podcast: Clearmind’s Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors – SciSparc (NASDAQ:SPRC), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds – Clearmind Medicine (NASDAQ:CMND) Read more
Cannabis Psyched: Suggestibility And Psychedelics’ Effects, EU’s $7M Research Fund, Australia’s Treatment Delivery, BZ Podcast And More – ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, ‘Synthetic Surprise,’ UK’s Harm Reduction Hub And More – Awakn Life Sciences (OTC:AWKNF), Clearmind Medicine (NASDAQ:CMND) Read more
